CPT Codes for COVID-19 Testing
The specific CPT codes for COVID-19 testing depend on the test type: use CPT 87635 for SARS-CoV-2 molecular/NAAT testing (the gold standard), and CPT 87426 for rapid antigen testing.
Understanding COVID-19 Test CPT Coding
The Current Procedural Terminology (CPT) coding system provides standardized numerical codes for reporting medical procedures, which is essential for reimbursement and compliance. For COVID-19 diagnostic testing, the codes vary based on the testing methodology employed.
Primary CPT Codes by Test Type
Molecular Testing (NAAT/RT-PCR):
- CPT 87635: SARS-CoV-2 amplified probe technique (the most commonly used code for molecular testing including RT-PCR, rapid molecular tests, and laboratory-based NAATs)
- This applies to both rapid molecular tests (≤60-minute turnaround) and standard laboratory-based nucleic acid amplification tests 1, 2
Antigen Testing:
- CPT 87426: SARS-CoV-2 antigen detection by immunoassay technique
- This covers both point-of-care rapid antigen tests and laboratory-based antigen immunoassays 2
Clinical Context for Test Selection
The choice between molecular and antigen testing impacts both clinical decision-making and coding:
For symptomatic patients suspected of COVID-19:
- NAAT (CPT 87635) is strongly recommended as the reference standard with highest sensitivity 1
- Antigen testing (CPT 87426) is acceptable when NAAT results would be delayed >1 day, though negative results require NAAT confirmation if clinical suspicion remains high 2
For asymptomatic exposed individuals:
- Either NAAT or antigen testing may be appropriate depending on timing and clinical context 1, 2
- Testing should occur at least 5 days post-exposure for optimal sensitivity
Important Coding Considerations
Specimen collection codes may be billed separately depending on payer policies and collection method (nasopharyngeal, anterior nares, midturbinate, saliva, etc.) 1, 2.
Common pitfall: Do not confuse the test methodology with the specimen type—the CPT code reflects the laboratory technique (molecular vs. antigen), not where the swab was obtained.
Point-of-care vs. laboratory-based testing both use the same CPT codes; the location of testing does not change the procedural code 2.
Additional Coding Notes
For home testing or self-collection scenarios, the same CPT codes apply when results are reported to healthcare providers for clinical decision-making 2. However, over-the-counter home tests purchased directly by patients without provider involvement typically are not billed using these codes.
Accurate CPT coding is crucial for appropriate reimbursement and compliance—erroneous coding can result in revenue loss or significant penalties 3.